Babies Living Safe and Smokefree
BLiSS
Multilevel Tobacco Intervention in Community Clinics for Underserved Families
1 other identifier
interventional
396
1 country
2
Brief Summary
The purpose of this randomized controlled trial is to develop and test the efficacy of a multilevel, multimodal intervention designed to modify maternal smoking behavior to reduce children's exposure to secondhand tobacco smoke (primary outcome) and promote their smoking cessation (secondary outcome). Low-income mothers who smoke will be enrolled. Mothers will be recruited from the supplemental nutrition program, Women, Infants and Children (WIC) clinics. All mothers visiting WIC clinics will receive a clinic-level intervention, which consists of nutrition counselors following an "ask, advise, and refer" protocol to identify if their children are exposed to secondhand tobacco smoke, advise mothers who smoke about the harms of such exposure and the benefits of reducing exposure, and referring mothers to the trial. Screened eligible mothers will be consented and randomized to an attention control condition focused on nutrition (CTL) or to an experimental (EXP) multimodal behavioral intervention that integrates telebased counseling to promote the reduction of child secondhand smoke exposure (SHSE) and maternal smoking with an adjunct smoking cessation mobile app and nicotine replacement therapy use. The investigators will test the primary hypothesis that relative to children in the CTL condition, those in the EXP condition will have lower exposure SHSE as measured by mothers' reports and child cotinine levels. The investigators will also test the secondary hypothesis that relative to mothers in the CTL condition, those in the EXP condition will have higher bioverified 7-day point prevalence quit rates. In addition, the study will: (a) evaluate if specific psychosocial and behavioral factors-- social support, urge coping skills, self-efficacy, and SHSe protective behaviors--mediate the effects of the EXP intervention on outcomes and (b) explore whether other residential smokers, level of nicotine dependence, depressive/anxious symptoms, weight concerns, intervention dosage, and pregnancy status predict outcomes and moderate treatment effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2015
CompletedFirst Posted
Study publicly available on registry
November 11, 2015
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2019
CompletedResults Posted
Study results publicly available
March 15, 2022
CompletedMarch 15, 2022
February 1, 2022
3.7 years
November 9, 2015
October 22, 2021
February 15, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Child Urine Cotinine
Child urine cotinine is a biomarker for assessing secondhand smoke exposure. The investigators anticipate the EXP group will evidence a greater reduction in child urine cotinine over time than the CTL group. Cotinine values were log transformed to normalize distributions.
3 months and 12 months
Cigarettes/Day
Parental report of cigarettes child is exposed to each day in the home and car and other locations by all sources during the 7 days prior to assessment. The investigators anticipate the EXP group will evidence greater reductions in child secondhand smoke exposure over time than the CTL group.
3 months and 12 months
Secondary Outcomes (1)
Parent-reported Cotinine-verified 7-day Point Prevalence Abstinence
7 days prior to 3 month and 12 month assessments
Study Arms (2)
AAR+Behavioral Intervention (EXP)
EXPERIMENTALAsk Advise Refer (AAR): WIC clinic staff ask about children's secondhand smoke exposure (SHSe), advise about harms of SHSe, and refer to smoking cessation resources. Telebased tobacco counseling: Telephone counseling to promote parent's smoking cessation and behaviors to protect children from secondhand tobacco smoke. Mobile phone smoking cessation application: Smartphone based application to support smoking cessation efforts. Nicotine polacrilex: Over the counter nicotine replacement therapy in gum or lozenge form.
AAR+Attention Control Intervention (CTL)
ACTIVE COMPARATORAsk Advise Refer (AAR): WIC clinic staff ask about children's secondhand smoke exposure (SHSe), advise about harms of SHSe, and refer to smoking cessation resources. Telebased nutrition counseling: Telephone counseling to promote nutritious eating practices in the family. Mobile phone nutrition application: Smartphone based application to support healthy eating habits
Interventions
WIC clinic staff ask about children's secondhand smoke exposure (SHSe), advise about harms of SHSe, and refer to smoking cessation resources
Telephone counseling to promote parent's smoking cessation and behaviors to protect children from secondhand tobacco smoke
Telephone counseling to promote nutritious eating practices in the family.
Smartphone based application to support smoking cessation efforts
Smartphone based application to support healthy eating habits
Over the counter nicotine replacement therapy in gum or lozenge form.
Eligibility Criteria
You may qualify if:
- English speaking
- female
- at least 18 years of age
- parent or legal guardian of child under 6 yrs old who lives with them at least 4 days/wk
- smokes
You may not qualify if:
- non-nicotine drug dependence
- active psychiatric disturbance (bipolar, schizophrenia, psychosis)
- inadequate health literacy
- pregnant
- no smartphone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Temple Universitylead
- N.O.R.T.H., Inc.collaborator
Study Sites (2)
Temple University
Philadelphia, Pennsylvania, 19122, United States
N.O.R.T.H., Inc.
Philadelphia, Pennsylvania, 19132, United States
Related Publications (4)
Collins BN, Lepore SJ, Egleston BL. Eliminating children's tobacco smoke exposure: a pathway to bioverified abstinence among low-income maternal smokers in the Babies Living Safe and Smokefree (BLiSS) trial. J Behav Med. 2023 Dec;46(6):1042-1048. doi: 10.1007/s10865-023-00423-9. Epub 2023 Jun 7.
PMID: 37285107DERIVEDCollins BN, Lepore SJ, Egleston BL. Multilevel Intervention for Low-Income Maternal Smokers in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). Am J Public Health. 2022 Mar;112(3):472-481. doi: 10.2105/AJPH.2021.306601.
PMID: 35196033DERIVEDLepore SJ, Collins BN, Killam HW, Barry B. Supportive Accountability and Mobile App Use in a Tobacco Control Intervention Targeting Low-Income Minority Mothers Who Smoke: Observational Study. JMIR Mhealth Uhealth. 2021 Jul 2;9(7):e28175. doi: 10.2196/28175.
PMID: 34255698DERIVEDCollins BN, Lepore SJ. Babies Living Safe & Smokefree: randomized controlled trial of a multilevel multimodal behavioral intervention to reduce low-income children's tobacco smoke exposure. BMC Public Health. 2017 Mar 14;17(1):249. doi: 10.1186/s12889-017-4145-7.
PMID: 28288601DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Limited generalizability of findings due to high rates of ineligibility (27.7%) and inability to contact (22.7%) among maternal smokers referred to the trial by WIC nutrition professionals who provided the clinic-level intervention.
Results Point of Contact
- Title
- Dr. Stephen Lepore
- Organization
- Temple University
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen J Lepore, PhD
Temple University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2015
First Posted
November 11, 2015
Study Start
February 1, 2016
Primary Completion
October 23, 2019
Study Completion
October 23, 2019
Last Updated
March 15, 2022
Results First Posted
March 15, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share